RE:RE:RE:52 WEEK LOW!Even for Bio this is under valued at current prices. Pressure could be from people trying to derisk possibly from the last PP as they never got a chance to sell with out a loss and now with trials in motion it's squeeze time. Ride the warrants. Anyways with no pressure it's a buyer's market so we will see how low they want to go. Just over a year ago I picked up some pretty cheap shares at .15 cents before FDA announcement would be happy to get some more freebies. Currently there is very little for IR to work with so I'm not surprised to see things lagging. That can change fast and we when it does we will see the pay off.